Passage Bio, Inc.
PASG
$8.49
$0.465.73%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -45.26M | -56.86M | -63.46M | -64.77M | -68.80M |
| Total Depreciation and Amortization | 1.27M | 1.85M | 2.48M | 3.08M | 3.17M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.28M | 19.44M | 20.23M | 17.75M | 9.37M |
| Change in Net Operating Assets | -3.76M | -504.00K | -2.11M | -4.02M | -2.76M |
| Cash from Operations | -33.47M | -36.07M | -42.87M | -47.96M | -59.03M |
| Capital Expenditure | -14.00K | -34.00K | -34.00K | -34.00K | -33.00K |
| Sale of Property, Plant, and Equipment | 1.17M | 1.17M | 585.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 52.74M | 67.73M | 68.78M | 54.98M | 48.90M |
| Cash from Investing | 53.89M | 68.86M | 69.33M | 54.95M | 48.87M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 61.00K | 61.00K | 132.00K | 8.87M | 8.87M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 61.00K | 61.00K | 132.00K | 8.87M | 8.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.48M | 32.86M | 26.58M | 15.86M | -1.29M |